MARKET

SXTPW

SXTPW

60 Degrees Pharm
NASDAQ
0.0537
+0.0098
+22.32%
Closed 14:13 12/26 EST
OPEN
0.0426
PREV CLOSE
0.0439
HIGH
0.0537
LOW
0.0426
VOLUME
1.35K
TURNOVER
--
52 WEEK HIGH
0.1560
52 WEEK LOW
0.0198
MARKET CAP
--
P/E (TTM)
-0.0093
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SXTPW last week (1215-1219)?
Weekly Report · 5d ago
Geoffrey S. Dow, President and CEO, Acquires Common Shares of 60 Degrees Pharmaceuticals Inc
Reuters · 12/16 22:42
Weekly Report: what happened at SXTPW last week (1208-1212)?
Weekly Report · 12/15 09:42
Geoffrey S. Dow, President and CEO, Acquires Common Shares of 60 Degrees Pharmaceuticals Inc
Reuters · 12/12 13:40
60 DEGREES PHARMACEUTICALS INC - TO ADD CLINICAL SITES FOR BABESIOSIS TRIALS
Reuters · 12/11 13:01
Weekly Report: what happened at SXTPW last week (1201-1205)?
Weekly Report · 12/08 09:41
Weekly Report: what happened at SXTPW last week (1124-1128)?
Weekly Report · 12/01 09:39
Weekly Report: what happened at SXTPW last week (1117-1121)?
Weekly Report · 11/24 09:42
More
About SXTPW
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years of age and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.

Webull offers 60 Degrees Pharmaceuticals Inc stock information, including NASDAQ: SXTPW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SXTPW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SXTPW stock methods without spending real money on the virtual paper trading platform.